Steroid resistant, osimertinib induced hypereosinophilic syndrome (HES) treated with Benralizumab in a patient with metastatic adenocarcinoma of lung.
Saved in:
| Title: | Steroid resistant, osimertinib induced hypereosinophilic syndrome (HES) treated with Benralizumab in a patient with metastatic adenocarcinoma of lung. |
|---|---|
| Authors: | Al Torkmani M; Internal Medicine Department, Sheikh Khalifa Medical City, Abu Dhabi United Arab Emirates., Abid H; Internal Medicine Department, Sheikh Khalifa Medical City, Abu Dhabi United Arab Emirates., Al Kassar Y; Pulmonology Department, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates., Al Maashari R; Pulmonology Department, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates., Gaba W; Internal Medicine Department, Sheikh Khalifa Medical City, Abu Dhabi United Arab Emirates., Athar S; Internal Medicine Department, Sheikh Khalifa Medical City, Abu Dhabi United Arab Emirates., Najib M; Pulmonology Department, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates., Tufail M; Pulmonology Department, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates. |
| Source: | Respiratory medicine case reports [Respir Med Case Rep] 2025 Nov 19; Vol. 58, pp. 102328. Date of Electronic Publication: 2025 Nov 19 (Print Publication: 2025). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101604463 Publication Model: eCollection Cited Medium: Print ISSN: 2213-0071 (Print) Linking ISSN: 22130071 NLM ISO Abbreviation: Respir Med Case Rep Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2213-0071 |
|---|---|
| DOI: | 10.1016/j.rmcr.2025.102328 |
